Description
This combination GLP-1/GIP agonist pen provides dual-pathway metabolic support, helping to regulate appetite and support weight-management outcomes within supervised clinical programmes.
Details
Strength: 0.5 mg / 5 mg per pen
Route: Subcutaneous injection only
Storage: 2–8 °C; protect from light.












Reviews
There are no reviews yet.